The U.S. Food and Drug Administration (FDA) has announced new regulations that will for the first time permit blood donations from homosexual and bisexual men.

The American Red Cross has already revised its donor screening guidelines to account for the move, doing away with a long-standing barrier that viewed patients’ sexual orientation and other aspects of the LGBT “rainbow” as severe risks.

Due to the horrifying sexual practices perpetrated by LGBT males, what was once considered possibly tainted or dirty blood is now a thing of the past as the American Red Cross adopts a new pro-gay position for blood donations.

The American Red Cross will no longer ask blood donors about their sexual orientation at the FDA’s request, citing “decades of data collection and assessments,” but they will still be questioned about deviant sexual behavior like anal sex, which if they commit will still require them to wait six months before trying to donate.

A New Study Claims gay, bisexual males are not having anal sex

In advance of the regulation change, the FDA carried out its own investigation known as ADVANCE. The organization has since said that sexual orientation is unimportant in terms of blood donations, including the waiting periods that the American Red Cross is maintaining for the time being.

The modification aligns the United States with more “progressive” nations like Canada and the United Kingdom, which already permit gay men to donate blood without raising any eyebrows.

According to the ADVANCE study, some sexually active gay and bisexual men who engage in “lower-risk behaviors” are nevertheless able to donate blood without any problems. A requirement of the FDA’s definition of “lower-risk behaviors” is the absence of new sex within the prior three months.

“There’s so much in the world that you can’t help with, and you sometimes have to see people going through difficult times, but something like giving blood feels like something so small that you can do, and it means a lot to me that I’ll be able to do that again,” celebrated Andrew Goldstein, an apparent LGBT himself and also a cancer researcher living in Los Angeles.

According to the ADVANCE study’s findings, 66 percent of gay and bisexual males said they had only one sexual partner and no anal intercourse. Sixty-nine percent of respondents stated that they had no anal sex or new partners within the previous three months.

According to the FDA, a gay or bisexual male who has just one partner and isn’t engaging in anal intercourse can donate blood without risk. However, any further dangerous behavior can make blood donation unsafe.

According to the American Red Cross, someone needs blood or platelets from a donor every two seconds in the United States. Red blood cell transfusions typically consist of three units, and 29,000 units are required daily to assist patients in need.

On average, a victim of a minor auto accident needs to receive 100 blood units. The FDA and the American Red Cross are altering the guidelines to allow more people to participate in the pool since LGBT perversion has spread like wildfire and disqualifies many people who would be eligible under the previous regulations.

“The Red Cross celebrates this historic move as significant progress and remains committed to achieving an inclusive blood donation process that treats all potential donors with equality and respect while maintaining the safety of the blood supply,” the non-profit organization said in a statement.

WATCH:

https://twitter.com/wolsned/status/1691196705708945410?s=20

Sputnik reported:

“The United States has started preparing for a new pandemic by searching for virus mutations, Lt. Gen. Igor Kirillov, a Russian senior military official, said

▪Announced in July of this year, the Biden Administration created the Office for Pandemic Preparedness and Response Policy.

▪This department’s priority areas include work on creating vaccines and drugs for stopping viruses and their genetically modified variants, Kirillov noted.

▪The leading role in the Pentagon’s military biological program will be played by the United States Army Medical Research Institute of Infectious Diseases, according to Kirillov.

▪Documents uncovered during the special military operation in Ukraine confirmed that this institution is involved in accumulating dangerous pathogens in various regions of the world, Kirillov added.”

Intel Republic also reported, by Kirillov:

“As in 2019, the United States has begun preparing for a new pandemic by looking for virus mutations.

We do not exclude the possible use of so-called defensive technologies for offensive purposes, as well as for the purpose of global control, by creating crises situations of a biological nature.”

The same Russian military commander who described the network of Bio Labs with ties to the United States that were discovered at the start of the Russian military operations in Ukraine is Kirillov.

You can read the full briefing here.

And below:

Briefing by Chief of Nuclear, Chemical, and Biological Protection Troops of the Armed Forces of the Russian Federation Lieutenant General Igor Kirillov on U.S. military-biological activity

The military and biological activities of the United States and its allies in Ukraine and on the soil of other nations are still being examined by the Russian Federation’s Ministry of Defense.

Many countries face a security concern as a result of US military biological operations.

Although the stated objectives of U.S. programs are to track disease prevalence and aid developing nations, in practice, we observe the Pentagon engaging in unrestricted dual-use research in violation of agreements made under the BTWC.

There is a clear trend: pathogens that fall within the Pentagon’s area of interest, such as COVID-19, avian influenza, African swine fever, subsequently become pandemic, and American pharmaceutical companies become the beneficiaries.

Earlier, we informed about the possible involvement of the U.S. Agency for International Development (USAID) in the emergence of the new coronavirus.

There is a clear trend: pathogens that fall within the Pentagon’s area of interest, such as COVID-19, avian influenza, African swine fever, subsequently become pandemic, and American pharmaceutical companies become the beneficiaries.

Earlier, we informed about the possible involvement of the U.S. Agency for International Development (USAID) in the emergence of the new coronavirus.
Projects to research this pathogen are implemented with the help of the EcoHealth Alliance intermediary organization. Since 2015, this company’s experts have been researching the diversity of the bat population in an effort to find new coronavirus strains and the processes by which they spread from animals to humans. Over 2,500 different beings have been studied in all.

I seem to recall that on October 18, 2019, John Hopkins University held the Event 201 exercise in novel York, two months before the first official news regarding the appearance of the novel coronavirus infection in China.

A suspected purposeful nature of COVID-19 and U.S. involvement in the disaster are questioned by the pandemic’s emergence in this scenario and the deployment of EcoHealth Alliance projects.

The next action the United States took was to establish the Office of Pandemic Preparedness and Response Policy in order to carry out its strategic goals for establishing worldwide biological control.

On July 21, 2023, the Office’s official formation was announced on the White House website.

The new institution is expected to be in charge of directing and coordinating efforts to counter known and unknow biological threats, including diseases that could spark another global disaster.

The development of vaccines and medications to treat viruses and their genetically modified versions, as well as the use of cutting-edge bioproduction technology, are among this office’s top priorities.

The structure will be led by retired Air Force Major General Paul Friedrichs, special assistant to the president and senior director for biodefense and global health security at the National Security Council.

In order to prepare for a new pandemic, the United States has started looking for virus mutations, much like in 2019. We do not completely rule out the possibility that the United States will deploy so-called defensive technologies for aggressive ends, as well as for global control by instigating biological crisis scenarios.

The biomedical warfare program of the military department will place a significant emphasis on the U.S. Army Research Institute for Infectious Diseases, which is currently led by Colonel Constance Jenkins.

It should be mentioned that the institute has a maximum biological containment level 4 (BSL-4) biolab and was founded at a bioweapons development facility at Fort Detrick.

It plays a significant role in the established Electronic Integrated Disease Surveillance System (EIDSS) of the Pentagon.

The institution is directly involved in the collection of dangerous pathogens in various parts of the world, the testing of illegal drugs, and the implementation of dual-use programs, according to documents obtained during the special military operation. These activities were ordered by the Defense Threat Reduction Agency of the U.S. Department of Defense (DTRA).

American biological programs in Ukraine have engaged the U.S. Army Institute of Infectious Diseases. As a result, members of the institute actively worked on the UP-1 and UP-8 projects. These studies looked into the potential for arthropods to transmit diseases like hantaviruses, tick-borne encephalitis virus, Congo-Crimean hemorrhagic fever, and rickettsiae.

In South America, Africa, Transcaucasia, and South-East Asia, the Institute has active agents. It is done in the laboratories of the Walter Reed Army Institute of Research and the Navy Medical Research Center.

U.S. Army Institute of Infectious Diseases personnel significantly increased their presence in these African nations in response to the 2014–2016 Ebola outbreak in Uganda, Kenya, Guinea, and Liberia in order to collect live viral samples of the fatal disease.

A full range of military-applied work with dangerous pathogens — components of biological weapons — can therefore be carried out, including work to enhance the pathogenic properties of pathogens of dangerous human and animal diseases. This is made possible by the Institute’s available production and experimental base.

Documents enabling the expansion of the Ukrainian military-biological dossier have been delivered to the Russian Federation’s Ministry of Defense.

Today we would like to supplement this list with representatives of Ukrainian State institutions and private companies, involved in the implementation of United States military-biological programs. They are:

Natalia Dudko served as the Project Coordinator and Senior Specialist of the STCU. For 25 years, she coordinated more than 250 STCU projects in various scientific fields.

Lyudmila Chernenko, General Director of the Centre for Public Health of the Ministry of Health of Ukraine. She is on the list of Ukrainian specialists, who have participated in U.S.-funded research projects.

Aleksandr Matskov, Deputy General Director of the Centre for Public Health of the Ministry of Health of Ukraine. He oversaw the overall implementation of a U.S.-funded dual-use project on COVID-19.

The Russian Defense Ministry continues to publish the names of officials of biotechnology corporations and other Pentagon contractors, involved in the implementation of U.S. military-biological programms on the territory of Ukraine.